Oncolytics Biotech (TSE:ONC) Stock Price Crosses Above 200 Day Moving Average – Here’s What Happened

by · The Cerbat Gem

Oncolytics Biotech Inc. (TSE:ONC – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$8.70 and traded as high as C$14.90. Oncolytics Biotech shares last traded at C$14.90, with a volume of 280 shares traded.

Oncolytics Biotech Stock Performance

The company’s 50 day simple moving average is C$14.90 and its 200-day simple moving average is C$8.76. The company has a quick ratio of 8.86, a current ratio of 2.99 and a debt-to-equity ratio of 11.75. The firm has a market cap of C$1.50 billion, a P/E ratio of -40.27 and a beta of 0.80.

Oncolytics Biotech (TSE:ONC – Get Free Report) last issued its quarterly earnings results on Wednesday, November 12th. The company reported C($0.14) earnings per share for the quarter. As a group, research analysts predict that Oncolytics Biotech Inc. will post -0.41 earnings per share for the current fiscal year.

About Oncolytics Biotech

(Get Free Report)

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.

See Also